Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
USD 0.67
(0.0%)
USD 0.67
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 319.6 Million USD | -29.8% |
| 2022 | 455.27 Million USD | -4.38% |
| 2021 | 476.12 Million USD | 31.78% |
| 2020 | 361.28 Million USD | 4.32% |
| 2019 | 346.31 Million USD | 29.13% |
| 2018 | 268.18 Million USD | 28.03% |
| 2017 | 209.47 Million USD | 23.96% |
| 2016 | 168.98 Million USD | -19.0% |
| 2015 | 208.63 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 87.46 Million USD | -24.22% |
| 2024 Q2 | 86.89 Million USD | -0.65% |
| 2023 Q4 | 115.41 Million USD | 109.88% |
| 2023 Q1 | 100.33 Million USD | -51.36% |
| 2023 Q2 | 198.83 Million USD | 98.17% |
| 2023 Q3 | 54.99 Million USD | -72.34% |
| 2023 FY | 319.6 Million USD | -29.8% |
| 2022 Q2 | 238.94 Million USD | 0.0% |
| 2022 FY | 455.27 Million USD | -4.38% |
| 2022 Q3 | 98.4 Million USD | -58.82% |
| 2022 Q4 | 206.29 Million USD | 109.63% |
| 2021 Q2 | 231.45 Million USD | 0.0% |
| 2021 FY | 476.12 Million USD | 31.78% |
| 2021 Q4 | 229.51 Million USD | 0.0% |
| 2020 FY | 361.28 Million USD | 4.32% |
| 2020 Q4 | 170.54 Million USD | 0.0% |
| 2019 FY | 346.31 Million USD | 29.13% |
| 2019 Q2 | 171.1 Million USD | 0.0% |
| 2019 Q4 | 165.57 Million USD | 0.0% |
| 2018 Q4 | 133.67 Million USD | 0.0% |
| 2018 FY | 268.18 Million USD | 28.03% |
| 2017 FY | 209.47 Million USD | 23.96% |
| 2016 FY | 168.98 Million USD | -19.0% |
| 2015 FY | 208.63 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -27352.439% |
| Ansell Limited | 129.3 Million USD | -147.182% |
| Ansell Limited | 129.3 Million USD | -147.182% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -926.414% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 20129.24% |
| Psykey, Inc. | -797.5 Thousand USD | 40175.886% |
| ConvaTec Group Plc | 262.7 Million USD | -21.662% |
| ConvaTec Group Plc | 262.7 Million USD | -21.662% |
| Encision Inc. | -640.78 Thousand USD | 49977.539% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 225476.765% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 290836.641% |
| Innovative MedTech Inc. | -4.27 Million USD | 7577.798% |
| LifePoint, Inc. | -7.49 Million USD | 4364.137% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 5032.204% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -96750.542% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 260175.507% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 68497.568% |
| SmileDirectClub, Inc. | -241.15 Million USD | 232.531% |
| Sector 10, Inc. | -39.84 Thousand USD | 802245.342% |
| SheerVision, Inc. | 155.72 Thousand USD | -205136.627% |
| United Health Products, Inc. | -2.42 Million USD | 13271.302% |
| Vasamed, Inc. | 4.74 Million USD | -6639.486% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 14031.436% |
| Yubo International Biotech Limited | -1.2 Million USD | 26618.477% |